Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status.
about
The Serotonin Receptor 6 Antagonist Idalopirdine and Acetylcholinesterase Inhibitor Donepezil Have Synergistic Effects on Brain Activity-A Functional MRI Study in the Awake RatSerotonergic Control of Metabolic Homeostasis.Trends in GPCR drug discovery: new agents, targets and indications.Age-related change in 5-HT6 receptor availability in healthy male volunteers measured with 11C-GSK215083 PET.5HT6 Antagonists in the Treatment of Alzheimer's Dementia: Current Progress.
P2860
Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Serotonin 5-HT6 Receptor Antag ...... nd Current Development Status.
@en
Serotonin 5-HT6 Receptor Antag ...... nd Current Development Status.
@nl
type
label
Serotonin 5-HT6 Receptor Antag ...... nd Current Development Status.
@en
Serotonin 5-HT6 Receptor Antag ...... nd Current Development Status.
@nl
prefLabel
Serotonin 5-HT6 Receptor Antag ...... nd Current Development Status.
@en
Serotonin 5-HT6 Receptor Antag ...... nd Current Development Status.
@nl
P2860
P50
P1433
P1476
Serotonin 5-HT6 Receptor Antag ...... nd Current Development Status.
@en
P2093
Maite Solas
P2860
P2888
P356
10.1007/S40263-016-0399-3
P577
2016-12-03T00:00:00Z